Japanese
English
Home
About Us
Our Mission
Leadership
Message from CEO
Corporate Information
Access
Our Science
PRIME Technology
Application of Our Technology
Pipelines
Our Partners
Careers
Contact Us
Contact Us
Create the Future to Overcome Cancer
News
2020/09/11
Announcement of New President
2020/09/11
Initiation of Phase I Clinical Trial of NIB 102 TAK 102
2020/06/04
Noile-Immune Biotech Enters Collaboration with Chugai Pharmaceutical on Technology Assessment
2020/05/26
C4U and Noile-Immune Biotech Partnership on PRIME Allogeneic CAR-T Cell Therapy Using CRISPR/Cas3 Genome Editing Technology
2020/05/05
Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and Licensing Agreement
Details
